Philips today announced the expansion of its strategic partnership with Sim&Cure, a provider of digital solutions for neurovascular therapy. The partnership between the two companies started five years ago and is now entering into a next phase with the aim to further enhance Philips’ position in the interventional neuro domain by integrating Sim&Size software into Philips’ next-generation Image-Guided Therapy platform – Azurion. The advanced connection offers care providers a more seamless, intuitive and efficient workflow for treating complex brain aneurysms. In addition, the two companies will be developing new synergies through common projects to drive innovation into the future of cathlabs.
Brain aneurysms, which affect around 3-5% of the general population, pose a significant challenge due to their complexity and the precision required for device placement. Current planning and device selection methods involve multiple manual steps, increasing both procedure time and variability. By integrating Sim&Size into Azurion, physicians can now simulate device placement, optimize selection, and guide deployment directly within the Azurion platform. This eliminates the need for separate software and hardware setups, enabling greater precision and efficiency in neurovascular procedures.
Philips’ image-guided therapy solutions help treat one patient every second, and for many of those, the Azurion platform is being used. Since its launch in 2017, Azurion has been used to treat more than five million patients in over 90 countries. Earlier this year, Philips introduced the latest version of Azurion, a biplane model designed specifically to support neuro interventions. It features enhanced 2D and 3D imaging capabilities, improved C-arm rotation flexibility, and optimized workflow features to help clinicians perform complex neurovascular procedures more effectively and efficiently.
